Vulnerability Management & Penetration Testing Puerto Rico
HIPAA, PCI-DSS and CMMC-aligned vulnerability scanning and authorized penetration testing for Puerto Ricou2019s pharmaceutical, healthcare and financial sectors
Puerto Ricou2019s regulatory environment creates specific, documented obligations for technical security testing. HIPAAu2019s Security Risk Analysis requirement u2014 the single most-cited deficiency in HHS OCR enforcement actions u2014 requires identifying and evaluating threats and vulnerabilities to ePHI. PCI-DSS Requirement 11.4 mandates annual penetration testing for any organization processing payment cards. CMMC Level 2 requires vulnerability scanning and remediation. For Puerto Ricou2019s pharmaceutical manufacturers, healthcare organizations, and financial institutions, vulnerability management and penetration testing are regulatory necessities, not optional enhancements.
HIPAA Security Risk Analysis Support
HHS OCRu2019s HIPAA audit protocol evaluates whether covered entities and business associates have conducted a thorough and accurate Security Risk Analysis (SRA) that identifies threats and vulnerabilities to ePHI. Vulnerability scanning is a foundational component of a defensible SRA u2014 providing documented evidence that technical vulnerabilities were systematically identified and evaluated.
GLADiiUMu2019s vulnerability management program for Puerto Rico healthcare clients generates SRA-ready documentation: a comprehensive inventory of ePHI-containing systems, identified vulnerabilities with risk ratings, existing controls evaluated against the vulnerability, and a prioritized remediation roadmap. This documentation satisfies HHS OCRu2019s SRA evidence requirements and supports defensible HIPAA compliance posture during audits and breach investigations.
Penetration Testing for Puerto Ricou2019s Pharmaceutical Sector
Puerto Ricou2019s pharmaceutical manufacturers face penetration testing requirements from multiple directions: FDA cyber guidance for drug manufacturing systems, client security requirements from multinational pharma companies, and SOC 2 or ISO 27001 audit requirements for supply chain security. GLADiiUMu2019s pharmaceutical penetration testing engagements are scoped to address manufacturing environment specifics u2014 separating IT and OT environments, accounting for GxP validation requirements that limit certain test techniques on production systems, and delivering findings documentation aligned to pharmaceutical regulatory expectations.
PCI-DSS Penetration Testing for Puerto Rico Retail and Hospitality
PCI-DSS Requirement 11.4 mandates external and internal penetration testing at least annually and after significant infrastructure changes for all organizations storing, processing, or transmitting payment card data. GLADiiUMu2019s PCI-scoped penetration tests for Puerto Rico retail, hospitality, and financial organizations include methodology documentation aligned to PCI Security Standards Council guidance and findings reports in the format required for QSA review.
Find Your Vulnerabilities Before HHS OCR or Attackers Do
GLADiiUM will conduct a free external attack surface assessment for your Puerto Rico organization u2014 scanning internet-facing assets, identifying critical vulnerabilities, and providing a prioritized remediation roadmap aligned to your HIPAA, PCI-DSS, or CMMC requirements.
English
Español